Minimally invasive spine firm NuVasive raises $15 million:
This article was originally published in Clinica
Private company NuVasive has completed a $15m equity financing, with investors including Johnson & Johnson Development Corporation. The San Diego, California-based company develops and markets systems for minimally invasive surgery for the spine. "The successful initial market introduction of our revolutionary NeuroVision system has solidified our proprietary position in surgeon-directed neurophysiologic minimal access of the spine," said Alex Lukianov, CEO. The company believes its "screw test" monitoring technology is the standard of care for all pedicle screw or revision cases.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.